2.63% 0.67

Stoke Therapeutics Inc (STOK)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Stoke Therapeutics Inc Azioni (STOK) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	49.70% 9.325	6.229	1.402	10.63	13.82
Operating Expenses	25.33% 74.75	59.65	62.84	53.72	41.12
Interest Income/Expense	26.09% 0.017	0.023	0.003	0.003	0.003
Operating Income/Loss	22.48% -65.43	-53.42	-61.44	-43.09	-27.30
Nonoperating Income/Loss	11.60% 3.811	3.415	3.505	3.466	3.817
Income/Loss From Continuing Operations Before Tax	23.23% -61.62	-50.00	-	-39.62	-23.48
Income Tax Expense/Benefit	-	-	-	-1.278	-
Net Income/Loss	23.23% -61.62	-50.00	-57.93	-38.35	-23.48
Basic Average Shares	4.68% 66.02	63.06	-	58.61	58.35
Diluted Average Shares	4.68% 66.02	63.06	-	58.61	58.35
Basic Earnings Per Share	17.72% -0.93	-0.79	-	-0.65	-0.40
Diluted Earnings Per Share	17.72% -0.93	-0.79	-	-0.65	-0.40

QURE

$24.28

12.15%

GENB

$13.21

6.96%

KLRA

$13.13

2.82%

MESO

$13.18

6.38%

URGN

$33.91

0.38%

NVAX

$10.02

6.60%